title: [A look back at 2 mumps outbreaks].
abstract: Two studies are presented. The first one concerns a mumps outbreak in a kindergarten in Geneva in June 1991. Of 26 children, nine (34.6%) got mumps. Of nine children vaccinated with the Rubini vaccine strain, seven had the disease as opposed to only one of 14 children vaccinated with the Urabe strain. The vaccine efficacy of the Rubini strain was estimated at 22% with a 95% confidence interval of -10% to 45%. The second study concerns a cluster of 112 mumps patients seen by a pediatrician in the Bernese Jura region between September 1992 and May 1993. A case-control study was carried out resulting in a vaccine efficacy estimate of 50% with a 95% confidence interval of -19% to 81%. Of the cases, 51 (45.5%) had been vaccinated against mumps, 50 of them (98%) with the Rubini vaccine strain. Of the controls, 30 (61.2%) had been vaccinated, 86.7% of them with Rubini. Methodological problems of case selection and their possible effects on the estimated vaccine efficacy are discussed. The results of these two studies have been confirmed by more recent investigations. In retrospect, we therefore conclude that small studies can serve as early indicators for epidemiological evidence and that they can be finally integrated into a more complete picture.
authors.affiliation: Laboratoire de virologie, Direction de la santé publique, Genève.
authors.forename: M F
authors.initials: MF
authors.lastname: Paccaud
authors.forename: P
authors.initials: P
authors.lastname: Hazeghi
authors.forename: M
authors.initials: M
authors.lastname: Bourquin
authors.forename: A M
authors.initials: AM
authors.lastname: Maurer
authors.forename: C A
authors.initials: CA
authors.lastname: Steiner
authors.forename: A J
authors.initials: AJ
authors.lastname: Seiler
authors.forename: P
authors.initials: P
authors.lastname: Helbling
authors.forename: H
authors.initials: H
authors.lastname: Zimmermann
mesh_terms: D002648:Child; D002675:Child, Preschool; D016001:Confidence Intervals; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control; D009108:Mumps Vaccine; D016017:Odds Ratio; D013557:Switzerland / Q000453:epidemiology
chemical_list: D009108:Mumps Vaccine
vernacular_title: Rückblick auf zwei Mumpsausbrüche.